Why you should attend Driving Commercial Value in Biotechs

Pharma IQ’s flagship one day biotech conference is a one day interactive forum providing you with the opportunity to gain the knowledge and ideas needed to ensure your biotech company secures the funding and partnerships it needs to succeed.

With 14 speakers packed into one full day of learning and knowledge-sharing, you will have the opportunity to overcome your principal challenges with the help of venture capitalists, industry company executives, and experts from large pharmaceutical companies.

This one day event will be an interactive learning forum focusing on the key commercial challenges facing biotech companies, including business development and investment, fund-raising and partnerships. Don’t miss your opportunity to learn from the best in the business!

Meet your panel of expert speakers

Chairman: Tony Jones, Director of Biotechnology and Healthcare, London First

• Dr Peter Luke, Senior Director, Worldwide Business Development, Pfizer
• Andy Sandham, Venture Partner, Abingworth LLP
• Tim Sparey, Associate Director, Scientifc Liaison, Merck Sharp & Dohme
• Tony Sedgwick, Chief Executive Officer, Novacta, former CEO Daniolabs, Cambridge Biotechnology
• Keith Martin, Chief Scientific Officer, Apitope
• Matthew Frohn, Oxford Technology VCT
• Dr Anne Bruinvels, Founder and Chief Scientific Officer, Curidium
• Patrick Doyle, Chief Scientific Officer, Syntaxin
• Dr Rebecca Todd, Investment Manager, Healthcare Technologies, Oxford Capital Partners
• Nicholas Adams, Director of Business Development, Antisoma
• Richard Palmer, Chairman, Warwick Effect Polymers
• Sonia Escaich, Chief Scientific Officer, Mutabilis
• Adrian Dawkes, Managing Consultant, Pharma Ventures

Why attend Pharma IQ’s Driving Commercial Value in Biotechs?

• Discover how to plan successfully to achieve investor liquidity with our unique biotech financing interactive forum. Led by 5 specialists and executives from venture capitalist firms and biotech companies, you will have the opportunity to here about experiences in all phases of this process
• Identify the key opportunities that large pharmaceutical companies look for in potential alliances and partnerships with biotechs, and understand the deal making process with case studies and examples from Merck Sharp & Dohme, and Pfizer
• Hear about a biotech company’s first deal and how to grow your strategic partnerships: Curidium will take you through their experiences
• Pinpoint how to build a sustainable valuation, and ascertain how venture capitalists look at valuation with a presentation from Oxford Capital Partners and Pharma Ventures
• Maximise your commercial deals by revolutionising your business model with case studies and a discussion led by Mutabilis

If you are not yet ready to register, feel free to request a reminder nearer the time .

[ Register Now] · [ Next: Conference Agenda: 7 July, 2008 ]